Verition Fund Management
AMED

Verition Fund Management’s Amedisys AMED Stock Holding History

Verition Fund Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-202,600
Closed -$18.4M – 3305
2024
Q4 		$18.4M Buy
+202,600
New +$18.6M 0.07% 266

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Verition Fund Management's AMED Position: Q3 2025 in Review

Verition Fund Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 7,814 shares — an estimated $769K sold.

Verition Fund Management first reported a position in AMED in Q3 2016 and held it in 18 quarters. The position peaked at $11.6M in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Verition Fund Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 7,814 Amedisys shares in Q3 2025, an estimated $769K.
  • Verition Fund Management first reported a position in Amedisys in Q3 2016 and held it in 18 quarters.
  • Verition Fund Management's Amedisys position peaked at $11.6M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.